Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A Bioequivalence Study of Ezetimibe/Rosuvastatin Fixed Dose Combination (10 mg/10 mg) Versus the Individual Formulations Taken Concomitantly.
Di Y, Wang Z, Jia C, Xie X, Yang S, Wang W, Xie X, Wang Q, Hu C, Xie F, Abdel-Moneim M, Hovsepian L, Wu Y, Yang N, Hou J. Di Y, et al. Among authors: hovsepian l. Adv Ther. 2023 May;40(5):2205-2216. doi: 10.1007/s12325-023-02439-8. Epub 2023 Mar 10. Adv Ther. 2023. PMID: 36897521 Free PMC article. Clinical Trial.
Determination of the Optimal Single Dose Treatment for Acoziborole, a Novel Drug for the Treatment of Human African Trypanosomiasis: First-in-Human Study.
Tarral A, Hovsepian L, Duvauchelle T, Donazzolo Y, Latreille M, Felices M, Gualano V, Delhomme S, Valverde Mordt O, Blesson S, Voiriot P, Strub-Wourgaft N. Tarral A, et al. Among authors: hovsepian l. Clin Pharmacokinet. 2023 Mar;62(3):481-491. doi: 10.1007/s40262-023-01216-8. Epub 2023 Feb 10. Clin Pharmacokinet. 2023. PMID: 36763327 Free PMC article. Clinical Trial.
Pharmacokinetic Interactions and Tolerability of Rosuvastatin and Ezetimibe: A Randomized, Phase 1, Crossover Study in Healthy Chinese Participants.
Wang L, Luan Y, Jia C, Xie X, Zhang Z, Xie X, Wang Q, Hu C, Xie F, Abdel-Moneim M, Hovsepian L, Zhao Z, Yang N, Hou J. Wang L, et al. Among authors: hovsepian l. Eur J Drug Metab Pharmacokinet. 2023 Jan;48(1):51-62. doi: 10.1007/s13318-022-00798-1. Epub 2022 Nov 27. Eur J Drug Metab Pharmacokinet. 2023. PMID: 36437383 Free PMC article. Clinical Trial.
Endothelial-protective effects of a G-protein-biased sphingosine-1 phosphate receptor-1 agonist, SAR247799, in type-2 diabetes rats and a randomized placebo-controlled patient trial.
Bergougnan L, Andersen G, Plum-Mörschel L, Evaristi MF, Poirier B, Tardat A, Ermer M, Herbrand T, Arrubla J, Coester HV, Sansone R, Heiss C, Vitse O, Hurbin F, Boiron R, Benain X, Radzik D, Janiak P, Muslin AJ, Hovsepian L, Kirkesseli S, Deutsch P, Parkar AA. Bergougnan L, et al. Among authors: hovsepian l. Br J Clin Pharmacol. 2021 May;87(5):2303-2320. doi: 10.1111/bcp.14632. Epub 2020 Nov 26. Br J Clin Pharmacol. 2021. PMID: 33125753 Free PMC article. Clinical Trial.
First-in-human study of the safety, tolerability, pharmacokinetics and pharmacodynamics of single and multiple oral doses of SAR247799, a selective G-protein-biased sphingosine-1 phosphate receptor-1 agonist for endothelial protection.
Bergougnan L, Armani S, Golor G, Tardat A, Vitse O, Hurbin F, Scemama M, Poitiers F, Radzik D, Gaudin C, Hovsepian L, Muslin AJ, Kirkesseli S, Deutsch P, Parkar AA. Bergougnan L, et al. Among authors: hovsepian l. Br J Clin Pharmacol. 2021 Feb;87(2):598-611. doi: 10.1111/bcp.14422. Epub 2020 Jul 8. Br J Clin Pharmacol. 2021. PMID: 32520410 Free PMC article. Clinical Trial.
Safety and Tolerability of Insulin Aspart Biosimilar SAR341402 Versus Originator Insulin Aspart (NovoLog) When Used in Insulin Pumps in Adults with Type 1 Diabetes: A Randomized, Open-Label Clinical Trial.
Thrasher J, Polsky S, Hovsepian L, Nowotny I, Pierre S, Bois De Fer B, Bhargava A, Mukherjee B, Garg SK. Thrasher J, et al. Among authors: hovsepian l. Diabetes Technol Ther. 2020 Sep;22(9):666-673. doi: 10.1089/dia.2019.0446. Epub 2020 Jan 28. Diabetes Technol Ther. 2020. PMID: 31833801 Free PMC article. Clinical Trial.
Determination of an optimal dosing regimen for fexinidazole, a novel oral drug for the treatment of human African trypanosomiasis: first-in-human studies.
Tarral A, Blesson S, Mordt OV, Torreele E, Sassella D, Bray MA, Hovsepian L, Evène E, Gualano V, Felices M, Strub-Wourgaft N. Tarral A, et al. Among authors: hovsepian l. Clin Pharmacokinet. 2014 Jun;53(6):565-80. doi: 10.1007/s40262-014-0136-3. Clin Pharmacokinet. 2014. PMID: 24535888 Free PMC article. Clinical Trial.
[Pharmacokinetic evaluation of linezolid in patients with major thermal injuries].
Le Floch R, Arnould JF, Vinsonneau C, Hovsepian L, Stephanazzi J, Bret P, Birraux G, Lovering AM. Le Floch R, et al. Among authors: hovsepian l. Pathol Biol (Paris). 2010 Apr;58(2):e27-31. doi: 10.1016/j.patbio.2009.07.025. Epub 2009 Oct 24. Pathol Biol (Paris). 2010. PMID: 19854590 Clinical Trial. French.
14 results